MyStroke: Personalized Patient and Caregiver Education After Stroke

Sponsor
University of Pennsylvania (Other)
Overall Status
Recruiting
CT.gov ID
NCT05118503
Collaborator
(none)
120
1
2
18.1
6.6

Study Details

Study Description

Brief Summary

This is a randomized pilot trial to evaluate the impact of a customizable stroke education app (vs standard of care discharge education) on patient satisfaction and education retention. The impact of the intervention will be assessed 7, 30, and 90 days post-discharge.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Customized education
  • Behavioral: Standard of care discharge education
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Personalized Patient and Caregiver Education After Stroke
Actual Study Start Date :
Sep 24, 2021
Anticipated Primary Completion Date :
Oct 31, 2022
Anticipated Study Completion Date :
Mar 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Customized education app

A customized URL-based platform will present brief education videos addressing a patients stroke etiology, risk factors, stroke prevention medications, and post-stroke lifestyle issues. This URL will be made available to the patient and caregiver.

Behavioral: Customized education
Half of subjects will receive access to a customized app that will include brief educational videos that have been selected for each patient based on their medical history. These videos will address stroke etiology, underlying risk factors, and stroke prevention medications.

Placebo Comparator: Standard of care discharge education

Standard discharge education is performed by the bedside nurse at the time of hospital discharge.

Behavioral: Standard of care discharge education
Half of subjects will be randomized to receive typical discharge education, per the institutional guidelines for standard of care education for stroke patients.

Outcome Measures

Primary Outcome Measures

  1. Patient satisfaction survey [Day 90]

    Likert-style survey assessing patient satisfaction and perception of the stroke education they received.

  2. Stroke Patient Education Retention (SPER) survey [Day 90]

    Validated measure of stroke patient education as it pertains to their stroke etiology and risk factors with scores of 0-10

  3. Euro Quality of Life (EuroQOL) survey [Day 90]

    validated quality of life metric, with scores of 0-100

Secondary Outcome Measures

  1. Stroke Impact Scale [Day 90]

    Standardized quality of life metric post stroke

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admitted for ischemic stroke

  • At least 18 years old

  • Patient or caregiver has access to a smart phone, tablet or computer

  • Being discharged to either home or acute rehab

Exclusion Criteria:
  • Patient or caregivers unable or unwilling to access the customized app with a smartphone, tablet, or computer

  • Being discharged to a skilled nursing facility

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital of the University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Pennsylvania

Investigators

  • Principal Investigator: Christopher Favilla, M.D., University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christopher Favilla, Assistant Professor of Neurology, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT05118503
Other Study ID Numbers:
  • 833723
First Posted:
Nov 12, 2021
Last Update Posted:
Nov 12, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 12, 2021